{"DataElement":{"publicId":"7976143","version":"2","preferredName":"COVID-19 Infection Complication Occurrence Type","preferredDefinition":"The type of complication experienced by the patient following the COVID-19 infection.","longName":"COV_INF_CMP_OCC_TYP","context":"NIH","contextVersion":"1","DataElementConcept":{"publicId":"7976140","version":"1","preferredName":"COVID-19 Infection Complication Occurrence","preferredDefinition":"An acute infection of the respiratory tract that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Based on currently available information, SARS-CoV-2 is thought to mainly spread from person to person through respiratory droplets. Typically, there is a two- to 14-day incubation period and infected persons can present with no symptoms or mild to severe fever, dry cough, fatigue, and difficulty breathing. Dysgeusia, anosmia, and gastrointestinal and flu-like symptoms have also been reported. Older adults and persons of any age who have serious underlying medical conditions may be of higher risk for severe illness, including secondary infections, respiratory failure, and multi-organ dysfunction._Any disease or disorder that occurs during the course of, or because of, another disease, treatment, or procedure._An instance of something happening, such as an event or incident.","longName":"7976138v1.0:2234856v1.0","context":"NIH","contextVersion":"1","ObjectClass":{"publicId":"7976138","version":"1","preferredName":"COVID-19 Infection Complication","preferredDefinition":"An acute infection of the respiratory tract that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Based on currently available information, SARS-CoV-2 is thought to mainly spread from person to person through respiratory droplets. Typically, there is a two- to 14-day incubation period and infected persons can present with no symptoms or mild to severe fever, dry cough, fatigue, and difficulty breathing. Dysgeusia, anosmia, and gastrointestinal and flu-like symptoms have also been reported. Older adults and persons of any age who have serious underlying medical conditions may be of higher risk for severe illness, including secondary infections, respiratory failure, and multi-organ dysfunction.:Any disease or disorder that occurs during the course of, or because of, another disease, treatment, or procedure.","longName":"C171133:C2959","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"COVID-19 Infection","conceptCode":"C171133","definition":"An acute infection of the respiratory tract that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Based on currently available information, SARS-CoV-2 is thought to mainly spread from person to person through respiratory droplets. Typically, there is a two- to 14-day incubation period and infected persons can present with no symptoms or mild to severe fever, dry cough, fatigue, and difficulty breathing. Dysgeusia, anosmia, and gastrointestinal and flu-like symptoms have also been reported. Older adults and persons of any age who have serious underlying medical conditions may be of higher risk for severe illness, including secondary infections, respiratory failure, and multi-organ dysfunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Complication","conceptCode":"C2959","definition":"Any disease or disorder that occurs during the course of, or because of, another disease, treatment, or procedure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2DE7CA5-01C1-3051-E053-4EBD850A6E3C","latestVersionIndicator":"Yes","beginDate":"2021-12-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-11","modifiedBy":"ONEDATA","dateModified":"2021-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2234856","version":"1","preferredName":"Occurrence","preferredDefinition":"Occurrence; an instance of something happening.","longName":"C25275","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Occurrence","conceptCode":"C25275","definition":"An instance of something happening, such as an event or incident.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9860F29-72B8-7421-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2DE7CA5-01CF-3051-E053-4EBD850A6E3C","latestVersionIndicator":"Yes","beginDate":"2021-12-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-11","modifiedBy":"KUMMEROA","dateModified":"2022-02-14","changeDescription":"2022-2-14 ak Released per DW review. 2021-12-11 ak Created for Project 5 Tier 1.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7976142","version":"2","preferredName":"COVID-19 Infection Complication Type","preferredDefinition":"An acute infection of the respiratory tract that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Based on currently available information, SARS-CoV-2 is thought to mainly spread from person to person through respiratory droplets. Typically, there is a two- to 14-day incubation period and infected persons can present with no symptoms or mild to severe fever, dry cough, fatigue, and difficulty breathing. Dysgeusia, anosmia, and gastrointestinal and flu-like symptoms have also been reported. Older adults and persons of any age who have serious underlying medical conditions may be of higher risk for severe illness, including secondary infections, respiratory failure, and multi-organ dysfunction._Any disease or disorder that occurs during the course of, or because of, another disease, treatment, or procedure._Something distinguishable as an identifiable class based on common qualities.","longName":"COV_INF_COMP_TYP","context":"NIH","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"55","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Deep Vein Thrombosis","valueDescription":"Deep Vein Thrombosis","ValueMeaning":{"publicId":"5296770","version":"1","preferredName":"Deep Vein Thrombosis","longName":"5296770","preferredDefinition":"A blood clot in a deep vein, predominantly in the lower extremity, but may include the pelvis or upper extremity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Deep Vein Thrombosis","conceptCode":"C49343","definition":"A blood clot in a deep vein, predominantly in the lower extremity, but may include the pelvis or upper extremity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3565D051-59F6-E09A-E050-BB89AD4359CB","latestVersionIndicator":"Yes","beginDate":"2016-06-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-16","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-E9CB-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Cardiomyopathy","valueDescription":"Cardiomyopathy","ValueMeaning":{"publicId":"2585212","version":"1","preferredName":"Cardiomyopathy","longName":"2585212","preferredDefinition":"A disease of the heart muscle or myocardium proper. Cardiomyopathies may be classified as either primary or secondary, on the basis of etiology, or on the pathophysiology of the lesion: hypertrophic, dilated, or restrictive.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cardiomyopathy","conceptCode":"C34830","definition":"A disease of the heart muscle or myocardium proper. Cardiomyopathies may be classified as either primary or secondary, on the basis of etiology, or on the pathophysiology of the lesion: hypertrophic, dilated, or restrictive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2687D788-9B74-74B4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-E9D5-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Bronchiolitis","valueDescription":"Bronchiolitis","ValueMeaning":{"publicId":"7976150","version":"1","preferredName":"Bronchiolitis","longName":"7976150v1.00","preferredDefinition":"Inflammation of the bronchioles characterized by swelling of the bronchioles and mucus accumulation. It is usually caused by the respiratory syncytial virus and affects children. Signs and symptoms include coughing, wheezing, and shortness of breath.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bronchiolitis","conceptCode":"C39658","definition":"Inflammation of the bronchioles characterized by swelling of the bronchioles and mucus accumulation. It is usually caused by the respiratory syncytial virus and affects children. Signs and symptoms include coughing, wheezing, and shortness of breath.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2DFDF8B-01F6-5E85-E053-4EBD850AD185","latestVersionIndicator":"Yes","beginDate":"2021-12-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-11","modifiedBy":"KUMMEROA","dateModified":"2023-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-E9DF-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Liver dysfunction","valueDescription":"Liver Dysfunction","ValueMeaning":{"publicId":"4291760","version":"1","preferredName":"Liver Dysfunction","longName":"4291760","preferredDefinition":"A finding that indicates abnormal liver function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liver Dysfunction","conceptCode":"C50634","definition":"A finding that indicates abnormal liver function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-643D-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-E9E9-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Myocarditis/Pericarditis","valueDescription":"Myocarditis Pericarditis","ValueMeaning":{"publicId":"7976151","version":"1","preferredName":"Myocarditis Pericarditis","longName":"7976151","preferredDefinition":"Inflammation of the muscle tissue of the heart.: An inflammatory process affecting the pericardium.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myocarditis","conceptCode":"C34831","definition":"Inflammation of the muscle tissue of the heart.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pericarditis","conceptCode":"C34915","definition":"An inflammatory process affecting the pericardium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2DFDF8B-0231-5E85-E053-4EBD850AD185","latestVersionIndicator":"Yes","beginDate":"2021-12-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-11","modifiedBy":"ONEDATA","dateModified":"2021-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-E9F3-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Acute renal failure","valueDescription":"Acute renal failure","ValueMeaning":{"publicId":"2943963","version":"1","preferredName":"Acute renal failure","longName":"2943963","preferredDefinition":"Sudden and sustained deterioration of the kidney function characterized by decreased glomerular filtration rate, increased serum creatinine or oliguria.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Renal Failure","conceptCode":"C26808","definition":"Sudden and sustained deterioration of the kidney function characterized by decreased glomerular filtration rate, increased serum creatinine or oliguria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"742CB3BE-B95F-F51E-E040-BB89AD432000","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-22","modifiedBy":"MAESKEB","dateModified":"2022-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-E9FD-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Pancreatitis","valueDescription":"Pancreatitis","ValueMeaning":{"publicId":"2559694","version":"1","preferredName":"Pancreatitis","longName":"2559694","preferredDefinition":"Inflammation of the pancreas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatitis","conceptCode":"C3306","definition":"Inflammation of the pancreas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B63B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EA07-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Pneumonia","valueDescription":"Pneumonia","ValueMeaning":{"publicId":"5296758","version":"1","preferredName":"Pneumonia","longName":"5296758","preferredDefinition":"An acute, acute and chronic, or chronic inflammation focally or diffusely affecting the lung parenchyma, due to infections (viruses, fungi, mycoplasma, or bacteria), treatment (e.g. radiation), or exposure (inhalation) to chemicals. Symptoms include cough, shortness of breath, fevers, chills, chest pain, headache, sweating, and weakness.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pneumonia","conceptCode":"C3333","definition":"An acute, acute and chronic, or chronic inflammation focally or diffusely affecting the lung parenchyma, due to infections (viruses, fungi, mycoplasma, or bacteria), treatment (e.g. radiation), or exposure (inhalation) to chemicals. Symptoms include cough, shortness of breath, fevers, chills, chest pain, headache, sweating, and weakness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3565B23F-B158-8338-E050-BB89AD437D10","latestVersionIndicator":"Yes","beginDate":"2016-06-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-06-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EA11-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Cardiac Arrhythmia","valueDescription":"Arrhythmia","ValueMeaning":{"publicId":"4733351","version":"1","preferredName":"Arrhythmia","longName":"4733351","preferredDefinition":"Any variation from the normal rate or rhythm (which may include the origin of the impulse and/or its subsequent propagation) in the heart.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Arrhythmia","conceptCode":"C2881","definition":"Any variation from the normal rate or rhythm (which may include the origin of the impulse and/or its subsequent propagation) in the heart.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"107BC70C-A38B-B0D0-E050-BB89AD432FE8","latestVersionIndicator":"Yes","beginDate":"2015-03-04","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-03-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EA1B-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Anemia","valueDescription":"Anemia","ValueMeaning":{"publicId":"4291759","version":"1","preferredName":"Anemia","longName":"4291759","preferredDefinition":"A reduction in the number of red blood cells, the amount of hemoglobin, and/or the volume of packed red blood cells. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anemia","conceptCode":"C2869","definition":"A reduction in the number of red blood cells, the amount of hemoglobin, and/or the volume of packed red blood cells. Clinically, anemia represents a reduction in the oxygen-transporting capacity of a designated volume of blood, resulting from an imbalance between blood loss (through hemorrhage or hemolysis) and blood production. Signs and symptoms of anemia may include pallor of the skin and mucous membranes, shortness of breath, palpitations of the heart, soft systolic murmurs, lethargy, and fatigability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8ABEA26-6419-ED7C-E040-BB89AD4312B2","latestVersionIndicator":"Yes","beginDate":"2014-05-05","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-05","modifiedBy":"ONEDATA_WA","dateModified":"2023-05-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EA25-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Endocarditis","valueDescription":"Endocarditis","ValueMeaning":{"publicId":"3210744","version":"1","preferredName":"Endocarditis","longName":"3210744","preferredDefinition":"Inflammation of the endocardium.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endocarditis","conceptCode":"C34582","definition":"Inflammation of the endocardium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-9860-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EA2F-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Peritonitis","valueDescription":"Peritonitis","ValueMeaning":{"publicId":"3251791","version":"1","preferredName":"Peritonitis","longName":"3251791","preferredDefinition":"Inflammation of the peritoneum (tissue that lines the abdominal wall and covers most of the organs in the abdomen). Peritonitis can result from infection, injury, or certain diseases. Symptoms may include swelling of the abdomen, severe pain, and weight loss.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Peritonitis","conceptCode":"C26849","definition":"Inflammation of the peritoneum due to infection by bacteria or fungi. Causes include liver disease, perforation of the gastrointestinal tract or biliary tract, and peritoneal dialysis. Patients usually present with abdominal pain and tenderness, fever, chills, and nausea and vomiting. It is an emergency medical condition that requires prompt medical attention and treatment.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A76B8D07-944C-4C3A-E040-BB89AD433F54","latestVersionIndicator":"Yes","beginDate":"2011-07-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EA39-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Diarrhea","valueDescription":"Diarrhea","ValueMeaning":{"publicId":"4395762","version":"1","preferredName":"Diarrhea","longName":"4395762","preferredDefinition":"Watery bowel movements.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diarrhea","conceptCode":"C2987","definition":"Watery bowel movements.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-D82F-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EA43-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Intestinal perforation","valueDescription":"Intestinal Perforation","ValueMeaning":{"publicId":"4394872","version":"1","preferredName":"Intestinal Perforation","longName":"4394872","preferredDefinition":"A rupture in the wall of the small or large intestine due to traumatic or pathologic processes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intestinal Perforation","conceptCode":"C39611","definition":"A rupture in the wall of the small or large intestine due to traumatic or pathologic processes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB5698F-C949-FBDD-E040-BB89AD431F32","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EA4D-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"COVID-19-Associated Acute liver injury","valueDescription":"COVID-19-Associated Acute Liver Injury","ValueMeaning":{"publicId":"7976153","version":"1","preferredName":"COVID-19-Associated Acute Liver Injury","longName":"7976153","preferredDefinition":"Acute liver injury caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"COVID-19-Associated Acute Liver Injury","conceptCode":"C171566","definition":"Acute liver injury caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2DFDF8B-02CB-5E85-E053-4EBD850AD185","latestVersionIndicator":"Yes","beginDate":"2021-12-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-11","modifiedBy":"ONEDATA","dateModified":"2021-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EA57-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Meningitis/encephalitis","valueDescription":"Meningitis Or Encephalitis","ValueMeaning":{"publicId":"7976154","version":"1","preferredName":"Meningitis Or Encephalitis","longName":"7976154","preferredDefinition":"A disorder characterized by acute inflammation of the meninges of the brain and/or spinal cord.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Inflammation of the BRAIN due to infection, autoimmune processes, toxins, and other conditions. Viral infections (see ENCEPHALITIS, VIRAL) are a relatively frequent cause of this condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Meningitis","conceptCode":"C26828","definition":"A disorder characterized by acute inflammation of the meninges of the brain and/or spinal cord.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Encephalitis","conceptCode":"C26760","definition":"An inflammatory process affecting the brain parenchyma. Causes include viral infections and less frequently bacterial infections, toxins, and immune-mediated processes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2DFDF8B-02F2-5E85-E053-4EBD850AD185","latestVersionIndicator":"Yes","beginDate":"2021-12-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-11","modifiedBy":"ONEDATA","dateModified":"2021-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EA61-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Seizure","valueDescription":"Seizure","ValueMeaning":{"publicId":"5026016","version":"1","preferredName":"Seizure","longName":"5026016","preferredDefinition":"Sudden, involuntary skeletal muscular contractions of cerebral or brain stem origin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Seizure","conceptCode":"C2962","definition":"Sudden, involuntary skeletal muscular contractions of cerebral or brain stem origin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"20D2C91D-B832-E866-E050-BB89AD433C74","latestVersionIndicator":"Yes","beginDate":"2015-09-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-09-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EA6B-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Bleeding","valueDescription":"Hemorrhage","ValueMeaning":{"publicId":"2561534","version":"1","preferredName":"Hemorrhage","longName":"2561534","preferredDefinition":"The flow of blood from a ruptured blood vessel.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemorrhage","conceptCode":"C26791","definition":"The flow of blood from a ruptured blood vessel.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-BD6B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-07-05","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-07-05","modifiedBy":"COOPERM","dateModified":"2017-08-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EA75-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Bacteremia","valueDescription":"Bacteremia","ValueMeaning":{"publicId":"7318748","version":"1","preferredName":"Bacteremia","longName":"7318748","preferredDefinition":"A laboratory test result that indicates the presence of bacteria in the blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bacteremia","conceptCode":"C102993","definition":"A laboratory test result that indicates the presence of bacteria in the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A75C5B2C-07DB-69BF-E053-4EBD850AEAF4","latestVersionIndicator":"Yes","beginDate":"2020-06-05","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2020-06-05","modifiedBy":"ONEDATA","dateModified":"2020-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EA7F-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Shock","valueDescription":"Shock","ValueMeaning":{"publicId":"4395648","version":"1","preferredName":"Shock","longName":"4395648","preferredDefinition":"A life-threatening condition that requires immediate medical intervention. It is characterized by reduced blood flow that may result in damage of multiple organs. Types of shock include cardiogenic, hemorrhagic, septic, anaphylactic, and traumatic shock.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Shock","conceptCode":"C35016","definition":"A life-threatening condition that requires immediate medical intervention. It is characterized by reduced blood flow that may result in damage of multiple organs. Types of shock include cardiogenic, hemorrhagic, septic, anaphylactic, and traumatic shock.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB79BBE-6B3F-5F7C-E040-BB89AD435DD5","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"MAESKEB","dateModified":"2022-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EA89-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Blood Clots","valueDescription":"Blood Clot","ValueMeaning":{"publicId":"2757885","version":"1","preferredName":"Blood Clot","longName":"2757885","preferredDefinition":"An aggregation of blood factors, primarily platelets and fibrin with entrapment of cellular elements, frequently causing vascular obstruction at the point of its formation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Blood Clot","conceptCode":"C27083","definition":"An aggregation of blood factors, primarily platelets and fibrin with entrapment of cellular elements, frequently causing vascular obstruction at the point of its formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F3F8B84-D608-3BC8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EA93-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Delirium","valueDescription":"Delirium","ValueMeaning":{"publicId":"2944316","version":"1","preferredName":"Delirium","longName":"2944316","preferredDefinition":"A usually reversible condition characterized by the acute and sudden development of confusion, illusions, movement changes, inattentiveness, agitation, and hallucinations. Causes include drug abuse, poisoning, infectious processes, and fluid and electrolyte imbalance.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Delirium","conceptCode":"C2981","definition":"A usually reversible condition characterized by the acute and sudden development of confusion, illusions, movement changes, inattentiveness, agitation, and hallucinations. Causes include drug abuse, poisoning, infectious processes, and fluid and electrolyte imbalance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74301D2A-4FF8-F34C-E040-BB89AD430317","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EA9D-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Venus Thromboembolism (VTE)","valueDescription":"Venous Thromboembolism","ValueMeaning":{"publicId":"3049884","version":"1","preferredName":"Venous Thromboembolism","longName":"3049884","preferredDefinition":"Occlusion of the lumen of a vein by a thrombus that has migrated from a distal site via the blood stream.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Venous Thromboembolism","conceptCode":"C99537","definition":"Occlusion of the lumen of a vein by a thrombus that has migrated from a distal site via the blood stream.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"838D91A3-8FFF-848A-E040-BB89AD433CBD","latestVersionIndicator":"Yes","beginDate":"2010-04-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-04-06","modifiedBy":"DWARZEL","dateModified":"2016-05-26","changeDescription":"Added LOINC code and name, also changed NCIt from post-coordinated to pre-coordinated concept.- DW 12-30-2015","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EAA7-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Arterial Thrombosis","valueDescription":"Arterial Thrombosis","ValueMeaning":{"publicId":"7359776","version":"1","preferredName":"Arterial Thrombosis","longName":"7359776","preferredDefinition":"Formation of a blood clot in the lumen of an artery.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Arterial Thrombosis","conceptCode":"C98826","definition":"Formation of a blood clot in the lumen of an artery.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AAA4B0B4-7721-0FA3-E053-4EBD850A83EA","latestVersionIndicator":"Yes","beginDate":"2020-07-17","endDate":null,"createdBy":"DWARZEL","dateCreated":"2020-07-17","modifiedBy":"ONEDATA","dateModified":"2020-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EAB1-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Pulmonary Embolism","valueDescription":"Pulmonary Embolism","ValueMeaning":{"publicId":"4395768","version":"1","preferredName":"Pulmonary Embolism","longName":"4395768","preferredDefinition":"The obstruction of the pulmonary artery or one of its branches by an embolus, sometimes associated with infarction of the lung.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pulmonary Embolism","conceptCode":"C50713","definition":"The obstruction of the pulmonary artery or one of its branches by an embolus, sometimes associated with infarction of the lung.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-D8E1-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EABB-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Physical disability/muscular weakness","valueDescription":"Physical Disability Muscle Weakness","ValueMeaning":{"publicId":"7976155","version":"1","preferredName":"Physical Disability Muscle Weakness","longName":"7976155","preferredDefinition":"Having substance or material existence; concerned with material things; of or pertaining to the body as distinguished from the mind or spirit.: Any physical or mental impairment that interferes with an individual's ability to perform desired activities.: A reduction in the strength of one or more muscles.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Physical","conceptCode":"C25618","definition":"Having substance or material existence; concerned with material things; of or pertaining to the body as distinguished from the mind or spirit.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Disability","conceptCode":"C21007","definition":"Any physical or mental impairment that interferes with an individual's ability to perform desired activities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Muscle Weakness","conceptCode":"C50658","definition":"A reduction in the strength of one or more muscles.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2E01D39-B2D4-3590-E053-4EBD850A5098","latestVersionIndicator":"Yes","beginDate":"2021-12-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-11","modifiedBy":"ONEDATA","dateModified":"2021-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EAC5-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Pulmonary aspergillosis","valueDescription":"Pulmonary Aspergillosis","ValueMeaning":{"publicId":"7976156","version":"1","preferredName":"Pulmonary Aspergillosis","longName":"7976156","preferredDefinition":"Having to do with the lungs.: An infectious fungal disease that occurs most often in the skin, ears, nasal sinuses, and lungs of people with suppressed immune systems.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pulmonary","conceptCode":"C13304","definition":"Relating to the lungs as the intended site of administration, where the pharmaceutical product is administered, usually by inhalation, for local action in the lower respiratory tract or for systemic action after absorption via the lower respiratory tract.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Aspergillosis","conceptCode":"C2886","definition":"An infection that is caused by Aspergillus.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2E01D39-B2FA-3590-E053-4EBD850A5098","latestVersionIndicator":"Yes","beginDate":"2021-12-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-11","modifiedBy":"ONEDATA","dateModified":"2021-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EACF-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"New onset diabetes","valueDescription":"New Onset Diabetes Mellitus","ValueMeaning":{"publicId":"7976157","version":"1","preferredName":"New Onset Diabetes Mellitus","longName":"7976157","preferredDefinition":"Having no previous example or precedent or parallel; of a kind not seen before.: The start, beginning, or early stages.: A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"New","conceptCode":"C25586","definition":"Having no previous example or precedent or parallel; of a kind not seen before.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Onset","conceptCode":"C25279","definition":"The start, beginning, or early stages.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diabetes Mellitus","conceptCode":"C2985","definition":"A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2E01D39-B321-3590-E053-4EBD850A5098","latestVersionIndicator":"Yes","beginDate":"2021-12-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-11","modifiedBy":"ONEDATA","dateModified":"2021-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EAD9-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Other, Specify","valueDescription":"If Other, Specify","ValueMeaning":{"publicId":"7557010","version":"1","preferredName":"If Other, Specify","longName":"7557010","preferredDefinition":"A directive to specify when the listed responses are not sufficient.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"If Other, Specify","conceptCode":"C157101","definition":"A directive to specify when the listed responses are not sufficient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9D26A12-EF66-4B33-E053-4EBD850ACC4C","latestVersionIndicator":"Yes","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-26","modifiedBy":"CLOHNES","dateModified":"2022-06-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EAE3-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"End Stage Renal Disease","valueDescription":"Chronic Kidney Disease, Stage 5","ValueMeaning":{"publicId":"4395774","version":"1","preferredName":"Chronic Kidney Disease, Stage 5","longName":"4395774","preferredDefinition":"Long-standing and persistent renal disease with glomerular filtration rate (GFR) less than 15 ml/min.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Kidney Disease, Stage 5","conceptCode":"C9439","definition":"Long-standing and persistent renal disease with glomerular filtration rate (GFR) less than 15 ml/min.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-D9B5-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"COOPERM","dateModified":"2019-03-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EAED-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Gastrointestinal hemorrhage","valueDescription":"Gastrointestinal Hemorrhage","ValueMeaning":{"publicId":"4293949","version":"1","preferredName":"Gastrointestinal Hemorrhage","longName":"4293949","preferredDefinition":"Bleeding originating from any part of the gastrointestinal tract.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastrointestinal Hemorrhage","conceptCode":"C48592","definition":"Bleeding originating from any part of the gastrointestinal tract.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8D473D5-41E7-380F-E040-BB89AD43084E","latestVersionIndicator":"Yes","beginDate":"2014-05-07","endDate":null,"createdBy":"SORENSENS","dateCreated":"2014-05-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EAF7-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Toxic shock syndrome","valueDescription":"Toxic Shock Syndrome","ValueMeaning":{"publicId":"4395684","version":"1","preferredName":"Toxic Shock Syndrome","longName":"4395684","preferredDefinition":"A severe illness caused by infection with staphylococcus aureus and characterized by high fever of sudden onset, vomiting, diarrhea, and myalgia, followed by hypotension and in severe cases, shock; a sunburn-like rash with peeling of the skin, especially of the palms and soles, occurs during the acute phase.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Toxic Shock Syndrome","conceptCode":"C35498","definition":"A rare acute life-threatening systemic bacterial noncontagious illness caused by any of several related staphylococcal exotoxins. It is characterized by high fever, hypotension, rash, multi-organ dysfunction, and cutaneous desquamation during the early convalescent period. The toxins affect the host immune system, causing an exuberant and pathological host inflammatory response. Laboratory findings include leukocytosis, elevated prothrombin time, hypoalbuminemia, hypocalcemia, and pyuria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB7F5B9-3120-D31B-E040-BB89AD436814","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EB01-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Appendicitis","valueDescription":"Acute Appendicitis","ValueMeaning":{"publicId":"2944024","version":"1","preferredName":"Acute Appendicitis","longName":"2944024","preferredDefinition":"Acute inflammation of the vermiform appendix.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Appendicitis","conceptCode":"C35145","definition":"Acute inflammation of the vermiform appendix.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"742DD56B-12EF-A7E6-E040-BB89AD43063D","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EB0B-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Diabetic ketoacidosis (DKA)","valueDescription":"Diabetic Ketoacidosis","ValueMeaning":{"publicId":"4395181","version":"1","preferredName":"Diabetic Ketoacidosis","longName":"4395181","preferredDefinition":"A type of metabolic acidosis produced by accumulation of ketone bodies resulting from uncontrolled diabetes mellitus.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diabetic Ketoacidosis","conceptCode":"C50530","definition":"The metabolic condition resulted from uncontrolled diabetes mellitus, in which the shift of acid-base status of the body toward the acid side because of loss of base or retention of acids other than carbonic acid is accompanied by the accumulation of ketone bodies in body tissues and fluids.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB64B44-1CC3-30C0-E040-BB89AD435920","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EB15-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Gastroesophageal reflux disease (GERD)","valueDescription":"Gastroesophageal Reflux Disease","ValueMeaning":{"publicId":"2944845","version":"1","preferredName":"Gastroesophageal Reflux Disease","longName":"2944845","preferredDefinition":"A chronic disorder characterized by reflux of the gastric and/or duodenal contents into the distal esophagus. It is usually caused by incompetence of the lower esophageal sphincter. Symptoms include heartburn and acid indigestion. It may cause injury to the esophageal mucosa.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastroesophageal Reflux Disease","conceptCode":"C26781","definition":"A chronic disorder characterized by reflux of the gastric and/or duodenal contents into the distal esophagus. It is usually caused by incompetence of the lower esophageal sphincter. Symptoms include heartburn and acid indigestion. It may cause injury to the esophageal mucosa.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"74450F48-355A-F0DB-E040-BB89AD437C48","latestVersionIndicator":"Yes","beginDate":"2009-09-23","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EB1F-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Arthritis","valueDescription":"Arthritis","ValueMeaning":{"publicId":"3292693","version":"1","preferredName":"Arthritis","longName":"3292693","preferredDefinition":"An inflammatory process affecting a joint. Causes include infection, autoimmune processes, degenerative processes, and trauma. Signs and symptoms may include swelling around the affected joint and pain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Arthritis","conceptCode":"C2883","definition":"An inflammatory process affecting a joint. Causes include infection, autoimmune processes, degenerative processes, and trauma. Signs and symptoms may include swelling around the affected joint and pain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEA65AE0-D99F-3EBD-E040-BB89AD431EBC","latestVersionIndicator":"Yes","beginDate":"2011-10-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EB29-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Myositis","valueDescription":"Myositis","ValueMeaning":{"publicId":"2945792","version":"1","preferredName":"Myositis","longName":"2945792","preferredDefinition":"An inflammatory process affecting the skeletal muscles. Causes include infections, injuries, and autoimmune disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myositis","conceptCode":"C27578","definition":"An inflammatory process affecting the skeletal muscles. Causes include infections, injuries, and autoimmune disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7458E815-92B7-DD76-E040-BB89AD43104A","latestVersionIndicator":"Yes","beginDate":"2009-09-24","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EB33-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Coronary artery abnormalities","valueDescription":"Coronary Artery Abnormality","ValueMeaning":{"publicId":"7976158","version":"1","preferredName":"Coronary Artery Abnormality","longName":"7976158","preferredDefinition":"One of two arteries that arise from the aortic sinuses of the ascending aorta and supply blood to the myocardium: A condition that differs from the usual physical or mental state.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Coronary Artery","conceptCode":"C12843","definition":"One of two arteries that arise from the aortic sinuses of the ascending aorta and supply blood to the myocardium","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Abnormality","conceptCode":"C9440","definition":"A condition that differs from the usual physical or mental state.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2E01D39-B3DB-3590-E053-4EBD850A5098","latestVersionIndicator":"Yes","beginDate":"2021-12-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-11","modifiedBy":"ONEDATA","dateModified":"2021-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EB3D-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Cardiac Failure","valueDescription":"Heart Failure","ValueMeaning":{"publicId":"4827929","version":"1","preferredName":"Heart Failure","longName":"4827929","preferredDefinition":"Inability of the heart to pump blood at an adequate rate to meet tissue metabolic requirements. Clinical symptoms of heart failure include: unusual dyspnea on light exertion, recurrent dyspnea occurring in the supine position, fluid retention or rales, jugular venous distension, pulmonary edema on physical exam, or pulmonary edema on chest x-ray presumed to be cardiac dysfunction.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Heart Failure","conceptCode":"C50577","definition":"Inability of the heart to pump blood at an adequate rate to meet tissue metabolic requirements. Clinical symptoms of heart failure include: unusual dyspnea on light exertion, recurrent dyspnea occurring in the supine position, fluid retention or rales, jugular venous distension, pulmonary edema on physical exam, or pulmonary edema on chest x-ray presumed to be cardiac dysfunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"166470EB-F439-9810-E050-BB89AD4311C9","latestVersionIndicator":"Yes","beginDate":"2015-05-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EB47-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Lung fibrosis","valueDescription":"Lung Fibrosis","ValueMeaning":{"publicId":"7976159","version":"1","preferredName":"Lung Fibrosis","longName":"7976159","preferredDefinition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.: The formation of fibrous tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung","conceptCode":"C12468","definition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Fibrosis","conceptCode":"C3044","definition":"The formation of fibrous tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2E01D39-B416-3590-E053-4EBD850A5098","latestVersionIndicator":"Yes","beginDate":"2021-12-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-11","modifiedBy":"ONEDATA","dateModified":"2021-12-11","changeDescription":"10.16.2020 Updated definition to match current NCIt. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EB51-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Deterioration of prior chronic pulmonary diseases","valueDescription":"Worse Prior Chronic Obstructive Pulmonary Disease","ValueMeaning":{"publicId":"7976160","version":"1","preferredName":"Worse Prior Chronic Obstructive Pulmonary Disease","longName":"7976160","preferredDefinition":"In an declined condition.: Earlier in time or order.: A chronic and progressive lung disorder characterized by the loss of elasticity of the bronchial tree and the air sacs, destruction of the air sacs wall, thickening of the bronchial wall, and mucous accumulation in the bronchial tree. The pathologic changes result in the disruption of the air flow in the bronchial airways. Signs and symptoms include shortness of breath, wheezing, productive cough, and chest tightness. The two main types of chronic obstructive pulmonary disease are chronic obstructive bronchitis and emphysema.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Worse","conceptCode":"C71686","definition":"In an declined condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Chronic Obstructive Pulmonary Disease","conceptCode":"C3199","definition":"A chronic and progressive lung disorder characterized by the loss of elasticity of the bronchial tree and the air sacs, destruction of the air sacs wall, thickening of the bronchial wall, and mucous accumulation in the bronchial tree. The pathologic changes result in the disruption of the air flow in the bronchial airways. Signs and symptoms include shortness of breath, wheezing, productive cough, and chest tightness. The two main types of chronic obstructive pulmonary disease are chronic obstructive bronchitis and emphysema.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2E01D39-B43E-3590-E053-4EBD850A5098","latestVersionIndicator":"Yes","beginDate":"2021-12-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-11","modifiedBy":"ONEDATA","dateModified":"2021-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EB5B-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Fibromyalgia/amplified pain syndrome","valueDescription":"Fibromyalgia Pain Amplification Syndrome","ValueMeaning":{"publicId":"7976162","version":"1","preferredName":"Fibromyalgia Pain Amplification Syndrome","longName":"7976162","preferredDefinition":"A chronic disorder of unknown etiology characterized by pain, stiffness, and tenderness in the muscles of neck, shoulders, back, hips, arms, and legs. Other signs and symptoms include headaches, fatigue, sleep disturbances, and painful menstruation.: A condition in which the nerves register normal stimuli (lack of tissue injury) as pain, resulting in feelings of intense pain with even minor sensory input.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fibromyalgia","conceptCode":"C87497","definition":"A chronic disorder of unknown etiology characterized by pain, stiffness, and tenderness in the muscles of neck, shoulders, back, hips, arms, and legs. Other signs and symptoms include headaches, fatigue, sleep disturbances, and painful menstruation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pain Amplification Syndrome","conceptCode":"C119048","definition":"A condition in which the nerves register normal stimuli (lack of tissue injury) as pain, resulting in feelings of intense pain with even minor sensory input.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2E01D39-B465-3590-E053-4EBD850A5098","latestVersionIndicator":"Yes","beginDate":"2021-12-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-11","modifiedBy":"ONEDATA","dateModified":"2021-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EB65-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Post viral fatigue syndrome","valueDescription":"Post Viral Fatigue Syndrome","ValueMeaning":{"publicId":"7976163","version":"1","preferredName":"Post Viral Fatigue Syndrome","longName":"7976163","preferredDefinition":"Happening at a time subsequent to a reference time; later in time or order.: Having to do with a virus.: Overall tiredness and lack of energy.: A group of signs, symptoms, and clinicopathological characteristics that may or may not have a genetic basis and collectively define an abnormal condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Post","conceptCode":"C38008","definition":"Happening at a time subsequent to a reference time; later in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Viral","conceptCode":"C27985","definition":"Having to do with a virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Fatigue","conceptCode":"C3036","definition":"Overall tiredness and lack of energy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Syndrome","conceptCode":"C28193","definition":"A group of signs, symptoms, and clinicopathological characteristics that may or may not have a genetic basis and collectively define an abnormal condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2E01D39-B48D-3590-E053-4EBD850A5098","latestVersionIndicator":"Yes","beginDate":"2021-12-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-11","modifiedBy":"ONEDATA","dateModified":"2021-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EB6F-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Multisystem Inflammatory Syndrome in Adults (MIS-A)","valueDescription":"Multisystem Inflammatory Syndrome in Adults","ValueMeaning":{"publicId":"7976164","version":"1","preferredName":"Multisystem Inflammatory Syndrome in Adults","longName":"7976164","preferredDefinition":"A rare syndrome found in adults with positive test results for SARS-CoV-2 by polymerase chain reaction or antibody assays indicating recent infection that is marked by cardiovascular, gastrointestinal, dermatologic, and neurologic symptoms without severe respiratory illness. The most common signs and symptoms that have been reported to date include fever, low blood pressure, abdominal pain, vomiting, diarrhea, neck pain, rash, chest pain, and tiredness not attributable to other infections.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multisystem Inflammatory Syndrome in Adults","conceptCode":"C178502","definition":"A rare syndrome found in adults with positive test results for SARS-CoV-2 by polymerase chain reaction or antibody assays indicating recent infection that is marked by cardiovascular, gastrointestinal, dermatologic, and neurologic symptoms without severe respiratory illness. The most common signs and symptoms that have been reported to date include fever, low blood pressure, abdominal pain, vomiting, diarrhea, neck pain, rash, chest pain, and tiredness not attributable to other infections.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2E01D39-B4B2-3590-E053-4EBD850A5098","latestVersionIndicator":"Yes","beginDate":"2021-12-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-11","modifiedBy":"ONEDATA","dateModified":"2021-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EB79-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Pediatric Multisystem Inflammatory Syndrome (MIS-C)","valueDescription":"Pediatric Multisystem Inflammatory Syndrome","ValueMeaning":{"publicId":"7976165","version":"1","preferredName":"Pediatric Multisystem Inflammatory Syndrome","longName":"7976165","preferredDefinition":"A rare syndrome temporally associated with COVID-19 in children, marked by persistent fever, inflammation (neutrophilia, elevated C-reactive protein (CRP), and lymphopenia), poor function in one or more organs, and other specific clinical and laboratory features not attributable to other infections. The characteristics of this syndrome appear to be similar to toxic shock syndrome and Kawasaki disease. The following variable signs and symptoms have been most commonly reported to date: coagulopathy, cardiac dysfunction, diarrhea, abdominal distension, other GI symptoms (with some children having positive stool tests for SARS-CoV-2), and acute kidney injury. Respiratory symptoms are not always a prominent feature in these cases.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multisystem Inflammatory Syndrome in Children","conceptCode":"C172127","definition":"A rare syndrome temporally associated with COVID-19 in children, marked by persistent fever, inflammation (neutrophilia, elevated C-reactive protein (CRP), and lymphopenia), poor function in one or more organs, and other specific clinical and laboratory features not attributable to other infections. The characteristics of this syndrome appear to be similar to toxic shock syndrome and Kawasaki disease. The following variable signs and symptoms have been most commonly reported to date: coagulopathy, cardiac dysfunction, diarrhea, abdominal distension, other GI symptoms (with some children having positive stool tests for SARS-CoV-2), and acute kidney injury. Respiratory symptoms are not always a prominent feature in these cases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2E01D39-B4D7-3590-E053-4EBD850A5098","latestVersionIndicator":"Yes","beginDate":"2021-12-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-11","modifiedBy":"MAESKEB","dateModified":"2022-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EB83-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Kawasaki Disease","valueDescription":"Kawasaki Disease","ValueMeaning":{"publicId":"3210750","version":"1","preferredName":"Kawasaki Disease","longName":"3210750","preferredDefinition":"A vasculitis characterized by inflammation of the arteries, particularly the coronary arteries. The vasculitis may lead to aneurysm formation and possibly, heart attacks. It affects young children who usually present with persistent high fever, redness of the mucous membranes of the mouth, redness of the palms and soles, skin rashes, lymphadenitis, and joint pain and swelling.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kawasaki Disease","conceptCode":"C34825","definition":"A vasculitis characterized by inflammation of the arteries, particularly the coronary arteries. The vasculitis may lead to aneurysm formation and possibly, heart attacks. It affects young children who usually present with persistent high fever, redness of the mucous membranes of the mouth, redness of the palms and soles, skin rashes, lymphadenitis, and joint pain and swelling.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-9990-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EB8D-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Stroke: intracerebral hemorrhage","valueDescription":"Cerebral Hemorrhage","ValueMeaning":{"publicId":"4395659","version":"1","preferredName":"Cerebral Hemorrhage","longName":"4395659","preferredDefinition":"Hemorrhage into the cerebrum. See also Stroke Syndrome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cerebral Hemorrhage","conceptCode":"C50485","definition":"Bleeding within the cerebrum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB79BBE-6C9F-5F7C-E040-BB89AD435DD5","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EB97-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Stroke: ischemic cerebrovascular accident","valueDescription":"Ischemic Cerebrovascular Accident","ValueMeaning":{"publicId":"3236724","version":"1","preferredName":"Ischemic Cerebrovascular Accident","longName":"3236724","preferredDefinition":"A sudden loss of neurological function secondary to ischemia in the brain parenchyma due to a vascular event.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ischemic Stroke","conceptCode":"C95802","definition":"An acute episode of focal cerebral, spinal, or retinal dysfunction caused by infarction of brain tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A3BC4428-F110-7327-E040-BB89AD4301BA","latestVersionIndicator":"Yes","beginDate":"2011-05-20","endDate":null,"createdBy":"LUY","dateCreated":"2011-05-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EBA1-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Acute respiratory distress syndrome (ARDS)","valueDescription":"Acute Respiratory Distress Syndrome","ValueMeaning":{"publicId":"4395685","version":"1","preferredName":"Acute Respiratory Distress Syndrome","longName":"4395685","preferredDefinition":"Progressive and life-threatening pulmonary distress in the absence of an underlying pulmonary condition, usually following major trauma or surgery. Cases of neonatal respiratory distress syndrome are not included in this definition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Respiratory Distress Syndrome","conceptCode":"C3353","definition":"Progressive and life-threatening pulmonary distress in the absence of an underlying pulmonary condition, usually following major trauma or surgery. Cases of neonatal respiratory distress syndrome are not included in this definition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB7F5B9-3158-D31B-E040-BB89AD436814","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"MAESKEB","dateModified":"2022-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EBAB-61F3-E053-4EBD850A2463","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Post-Acute Sequelae of COVID-19","valueDescription":"Post-Acute Sequelae of COVID-19","ValueMeaning":{"publicId":"7976519","version":"1","preferredName":"Post-Acute Sequelae of COVID-19","longName":"7976519","preferredDefinition":"A constellation of signs and symptoms that can persist for weeks or months after acute infection with SARS-CoV-2, or appear weeks after infection.  This condition may be characterized by fatigue, shortness of breath, difficulty focusing or concentrating (\"brain fog\"), sleep disorders, fevers, gastrointestinal symptoms, anxiety, and depression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Post-Acute Sequelae of COVID-19","conceptCode":"C179263","definition":"A constellation of signs and symptoms that can persist for weeks or months after acute infection with SARS-CoV-2, or appear weeks after infection.  This condition may be characterized by fatigue, shortness of breath, difficulty focusing or concentrating (\"brain fog\"), sleep disorders, fevers, gastrointestinal symptoms, anxiety, and depression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D3093587-6C68-19C2-E053-4EBD850A76AB","latestVersionIndicator":"Yes","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EBC8-61F3-E053-4EBD850A2463","beginDate":"2022-02-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Thrombocytopenia","valueDescription":"Thrombocytopenia","ValueMeaning":{"publicId":"2946035","version":"1","preferredName":"Thrombocytopenia","longName":"2946035","preferredDefinition":"A condition in which there is an abnormally small number of platelets in the circulating blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thrombocytopenia","conceptCode":"C3408","definition":"A laboratory test result indicating that there is an abnormally small number of platelets in the circulating blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D443-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EBD3-61F3-E053-4EBD850A2463","beginDate":"2022-02-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Rhabdomyolysis","valueDescription":"Rhabdomyolysis","ValueMeaning":{"publicId":"8062260","version":"1","preferredName":"Rhabdomyolysis","longName":"8062260","preferredDefinition":"A clinical syndrome resulting from direct or indirect muscle injury and subsequent release of myoglobin into the plasma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rhabdomyolysis","conceptCode":"C118318","definition":"A clinical syndrome resulting from direct or indirect muscle injury and subsequent release of myoglobin into the plasma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9197F23-EBE0-61F3-E053-4EBD850A2463","latestVersionIndicator":"Yes","beginDate":"2022-02-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EBF9-61F3-E053-4EBD850A2463","beginDate":"2022-02-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Thrombosis","valueDescription":"Thrombosis","ValueMeaning":{"publicId":"4792371","version":"1","preferredName":"Thrombosis","longName":"4792371","preferredDefinition":"The formation of a blood clot in the lumen of a vessel or heart chamber; causes include coagulation disorders and vascular endothelial injury.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thrombosis","conceptCode":"C26891","definition":"The formation of a blood clot in the lumen of a vessel or heart chamber; causes include coagulation disorders and vascular endothelial injury.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"13DA6467-E753-681F-E050-BB89AD4305DE","latestVersionIndicator":"Yes","beginDate":"2015-04-16","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EC03-61F3-E053-4EBD850A2463","beginDate":"2022-02-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Disseminated Intravascular Coagulation (DIC)","valueDescription":"Disseminated Intravascular Coagulation","ValueMeaning":{"publicId":"2944510","version":"1","preferredName":"Disseminated Intravascular Coagulation","longName":"2944510","preferredDefinition":"A pathological process where the blood starts to coagulate throughout the whole body. This depletes the body of its platelets and coagulation factors, and there is an increased risk of hemorrhage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disseminated Intravascular Coagulation","conceptCode":"C2992","definition":"A pathological process where the blood starts to coagulate throughout the whole body. This depletes the body of its platelets and coagulation factors, and there is an increased risk of hemorrhage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"743C896C-1FA9-79F1-E040-BB89AD4359CF","latestVersionIndicator":"Yes","beginDate":"2009-09-23","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-09-23","modifiedBy":"MAESKEB","dateModified":"2022-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EC17-61F3-E053-4EBD850A2463","beginDate":"2022-02-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Acute Cardiac Injury","valueDescription":"Acute Heart Injury","ValueMeaning":{"publicId":"8062261","version":"1","preferredName":"Acute Heart Injury","longName":"8062261","preferredDefinition":"Having a severe and rapid onset of symptoms with short duration.: A hollow organ located slightly to the left of the middle portion of the chest. It is composed of muscle and it is divided by a septum into two sides: the right side which receives de-oxygenated blood from the body and the left side which sends newly oxygenated blood to the body. Each side is composed of two chambers: the atrium (receiving blood) and ventricle (ejecting blood).: Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute","conceptCode":"C14140","definition":"Having a severe and rapid onset of symptoms with short duration.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Heart","conceptCode":"C12727","definition":"A hollow organ located slightly to the left of the middle portion of the chest. It is composed of muscle and it is divided by a septum into two sides: the right side which receives de-oxygenated blood from the body and the left side which sends newly oxygenated blood to the body. Each side is composed of two chambers: the atrium (receiving blood) and ventricle (ejecting blood).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Injury","conceptCode":"C3671","definition":"Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9197F23-EC26-61F3-E053-4EBD850A2463","latestVersionIndicator":"Yes","beginDate":"2022-02-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EC41-61F3-E053-4EBD850A2463","beginDate":"2022-02-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Acute Liver Injury","valueDescription":"Acute Liver Injury","ValueMeaning":{"publicId":"8062262","version":"1","preferredName":"Acute Liver Injury","longName":"8062262","preferredDefinition":"Having a severe and rapid onset of symptoms with short duration.: A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.: Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute","conceptCode":"C14140","definition":"Having a severe and rapid onset of symptoms with short duration.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Liver","conceptCode":"C12392","definition":"A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Injury","conceptCode":"C3671","definition":"Damage inflicted on the body as the direct or indirect result of an external force, with or without disruption of structural continuity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9197F23-EC4F-61F3-E053-4EBD850A2463","latestVersionIndicator":"Yes","beginDate":"2022-02-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EC68-61F3-E053-4EBD850A2463","beginDate":"2022-02-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"Acute Respiratory Failure","valueDescription":"Acute Respiratory Failure","ValueMeaning":{"publicId":"8062264","version":"1","preferredName":"Acute Respiratory Failure","longName":"8062264","preferredDefinition":"Life-threatening respiratory failure that develops rapidly. Causes include injury, sepsis, drug overdose, and pancreatitis. It manifests with dyspnea and cyanosis and may lead to cardiovascular shock.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Respiratory Failure","conceptCode":"C27043","definition":"Life-threatening respiratory failure that develops rapidly. Causes include injury, sepsis, drug overdose, and pancreatitis. It manifests with dyspnea and cyanosis and may lead to cardiovascular shock.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9197F23-EC75-61F3-E053-4EBD850A2463","latestVersionIndicator":"Yes","beginDate":"2022-02-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-EC8E-61F3-E053-4EBD850A2463","beginDate":"2022-02-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"},{"value":"No other complications","valueDescription":"No Other Complication","ValueMeaning":{"publicId":"8062265","version":"1","preferredName":"No Other Complication","longName":"8062265","preferredDefinition":"The non-affirmative response to a question.: Different than the one(s) previously specified or mentioned.: Any disease or disorder that occurs during the course of, or because of, another disease, treatment, or procedure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Complication","conceptCode":"C2959","definition":"Any disease or disorder that occurs during the course of, or because of, another disease, treatment, or procedure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9197F23-EC9C-61F3-E053-4EBD850A2463","latestVersionIndicator":"Yes","beginDate":"2022-02-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9197F23-ECB7-61F3-E053-4EBD850A2463","beginDate":"2022-02-28","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"ONEDATA","dateModified":"2022-02-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7976141","version":"1","preferredName":"COVID-19 Infection Complication Type","preferredDefinition":"An acute infection of the respiratory tract that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Based on currently available information, SARS-CoV-2 is thought to mainly spread from person to person through respiratory droplets. Typically, there is a two- to 14-day incubation period and infected persons can present with no symptoms or mild to severe fever, dry cough, fatigue, and difficulty breathing. Dysgeusia, anosmia, and gastrointestinal and flu-like symptoms have also been reported. Older adults and persons of any age who have serious underlying medical conditions may be of higher risk for severe illness, including secondary infections, respiratory failure, and multi-organ dysfunction.:Any disease or disorder that occurs during the course of, or because of, another disease, treatment, or procedure.:Something distinguishable as an identifiable class based on common qualities.","longName":"C171133:C2959:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"COVID-19 Infection","conceptCode":"C171133","definition":"An acute infection of the respiratory tract that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Based on currently available information, SARS-CoV-2 is thought to mainly spread from person to person through respiratory droplets. Typically, there is a two- to 14-day incubation period and infected persons can present with no symptoms or mild to severe fever, dry cough, fatigue, and difficulty breathing. Dysgeusia, anosmia, and gastrointestinal and flu-like symptoms have also been reported. Older adults and persons of any age who have serious underlying medical conditions may be of higher risk for severe illness, including secondary infections, respiratory failure, and multi-organ dysfunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Complication","conceptCode":"C2959","definition":"Any disease or disorder that occurs during the course of, or because of, another disease, treatment, or procedure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D2DF30C2-D502-51E2-E053-4EBD850A48F8","latestVersionIndicator":"Yes","beginDate":"2021-12-11","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-11","modifiedBy":"ONEDATA","dateModified":"2021-12-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9197F23-E9B5-61F3-E053-4EBD850A2463","latestVersionIndicator":"Yes","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"KUMMEROA","dateModified":"2023-08-22","changeDescription":"2022-2-14 ak Released per DW review. 2021-12-11 ak Created for Project 5 Tier 1. 2022-02-28 versioned per Denise W. to add PVs bsm.","administrativeNotes":"2023.8.22 Updated PV def for 'No Value Exists'. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]},{"publicId":"7244861","version":"1","longName":"COVID-19","context":"NCIP","ClassificationSchemeItems":[{"publicId":"8038915","version":"1","longName":"NIH","context":"NCIP"},{"publicId":"8038916","version":"1","longName":"Project 5 CDEs","context":"NCIP"}]},{"publicId":"7977821","version":"1","longName":"Project 5 COVID","context":"NIH","ClassificationSchemeItems":[{"publicId":"7977823","version":"1","longName":"Tier 1","context":"NIH"}]}],"AlternateNames":[{"name":"COVID-19 Complication Type","type":"NIH COVID","context":"NIH"},{"name":"COG","type":"USED_BY","context":"COG"}],"ReferenceDocuments":[{"name":"COG CRF text 1","type":"Alternate Question Text","description":"Did patient have any other complications related to SARS CoV-2 infection?","url":null,"context":"COG"},{"name":"Did the patient develop any o","type":"Preferred Question Text","description":"Did the patient develop any of the following complications as a result of COVID:","url":null,"context":"NIH"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9199812-EFEE-50C8-E053-4EBD850A2C52","latestVersionIndicator":"Yes","beginDate":"2021-12-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2022-02-28","modifiedBy":"COOPERJ","dateModified":"2022-03-01","changeDescription":"2022-2-14 ak Released per DW review. 2021-12-11 ak Created for Project 5 Tier 1.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}